NCT00289913 arm group a27c741822ddb2f00f3f7fb997a23398 [clinicaltrials_resource:NCT00289913/arm-group/a27c741822ddb2f00f3f7fb997a23398]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00289913 arm group a27c741822ddb2f00f3f7fb997a23398 [clinicaltrials_resource:NCT00289913/arm-group/a27c741822ddb2f00f3f7fb997a23398]
Bio2RDF identifier
NCT00289913/arm-group/a27c741822ddb2f00f3f7fb997a23398
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 7c741822ddb2f00f3f7fb997a23398
description [clinicaltrials_vocabulary:description]
Day 1: VAQTA™ (first dose), ...... se of VAQTA™ was administered.
identifier
clinicaltrials_resource:NCT00289913/arm-group/a27c741822ddb2f00f3f7fb997a23398
title
NCT00289913 arm group a27c741822ddb2f00f3f7fb997a23398
@en
type
label
NCT00289913 arm group a27c7418 ...... c741822ddb2f00f3f7fb997a23398]
@en